Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

Wellbeing Digital Sciences Inc (MEDI)

CBOE Canada
Currency in CAD
Disclaimer
0.0100
0.0000(0.00%)
Closed

MEDI Comments

More and more research studies are showing positive outcomes for using ketamine to treat depression in adults. A growing number of studies show that this “party drug” actually helps treat depression, post-traumatic stress disorder and other behavioural health/psychiatric disorders. Since ketamine has already been around for decades, it has been deemed safe, unlike many newer treatments and drugs, which still have unknown long-term effects. One of my favourite companies in the space, KetmineOne, has a few interesting things that separates them from the competition. They use a first-of-it’s-kind wearable device to track before, during, and post-treatment of patients during psychedelic-assisted therapies (adjust clinical processes based on patient reactions to specific treatments), already established with 16 operating clinics across Canada with many more planned for North America (target at 30 clinics), they wereounded in 1997, and have both experience and history in the area. Since they're already pre-established its a far safer investment compared to other psychedelics companies. With growing revenues and more clinics opening up, $MEDI will stay in my portfolio for a while.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.